Lactiga named a Semi-Finalist in the XPRIZE Rapid Covid Testing Competition

Sep 12, 2020 | Announcements

Lactiga has been advanced to the Semi-Final stage of the XPRIZE Rapid Covid Testing Competition, a $5 million dollar, 6-month competition to develop faster, cheaper, and easier to use COVID-19 testing methods at scale.

Lactiga featured in the Globe and Mail

Lactiga was featured in The Globe and Mail for its COVID-19 therapeutics program:

Lactiga featured in the Toronto Star

Lactiga’s R&D on milk antibodies against COVID-19 was featured in the Toronto Star, one of Canada’s largest newspapers: